Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

TPG

TPG Inc

Sep 20 • 04:00PM ET

58.72

Dollar change -0.61
Percentage change -1.03	%

Financial • Asset Management • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VB VBR VXF SCHA VYM IWR PSP FNDA DES

Index	-	P/E	-	EPS (ttm)	-0.34	Insider Own	13.37%	Shs Outstand	96.27M	Perf Week	4.04%
Market Cap	5.65B	Forward P/E	22.09	EPS next Y	2.66	Insider Trans	-0.03%	Shs Float	83.40M	Perf Month	18.65%
Income	17.60M	PEG	-	EPS next Q	0.47	Inst Own	78.23%	Short Float	4.96%	Perf Quarter	42.49%
Sales	2.71B	P/S	2.09	EPS this Y	26.79%	Inst Trans	1.82%	Short Ratio	4.29	Perf Half Y	26.12%
Book/sh	6.95	P/B	8.45	EPS next Y	33.52%	ROA	0.20%	Short Interest	4.14M	Perf Year	91.27%
Cash/sh	11.78	P/C	4.98	EPS next 5Y	29.38%	ROE	2.83%	52W Range	26.62 - 60.35	Perf YTD	36.02%
Dividend Est.	1.70 (2.89%)	P/FCF	91.41	EPS past 5Y	-	ROI	0.91%	52W High	-2.71%	Beta	1.52
Dividend TTM	1.75 (2.98%)	Quick Ratio	-	Sales past 5Y	29.25%	Gross Margin	96.45%	52W Low	120.59%	ATR (14)	1.70
Dividend Ex-Date	Aug 16, 2024	Current Ratio	-	EPS Y/Y TTM	-80.99%	Oper. Margin	-0.76%	RSI (14)	76.56	Volatility	2.81% 2.78%
Employees	1850	Debt/Eq	1.72	Sales Y/Y TTM	21.75%	Profit Margin	0.65%	Recom	2.07	Target Price	51.29
Option/Short	Yes / Yes	LT Debt/Eq	1.72	EPS Q/Q	-1327.15%	Payout	-	Rel Volume	1.81	Prev Close	59.33
Sales Surprise	-0.53%	EPS Surprise	14.92%	Sales Q/Q	23.04%	Earnings	Aug 06 BMO	Avg Volume	963.78K	Price	58.72
SMA20	12.82%	SMA50	19.44%	SMA200	33.14%	Trades		Volume	1,745,374	Change	-1.03%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-12-24	Initiated	Wells Fargo	Overweight	$60
May-10-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$43 → $52
Jan-04-24	Initiated	TD Cowen	Market Perform	$38
Dec-06-23	Resumed	BMO Capital Markets	Market Perform	$36
Nov-30-23	Resumed	Goldman	Buy	$43
May-19-23	Initiated	Citigroup	Buy	$32
Jan-24-23	Downgrade	JP Morgan	Overweight → Neutral	$35 → $34
Oct-19-22	Initiated	Credit Suisse	Neutral	$27.50
Oct-17-22	Initiated	Jefferies	Hold	$30
Oct-14-22	Downgrade	Exane BNP Paribas	Outperform → Neutral	$32
Jun-08-22	Initiated	JMP Securities	Mkt Perform

Show Previous Ratings

Sep-16-24 09:05PM	TPG Angelo Gordon, Dream Unlimited Corp., and Stadium Capital Partners to Acquire Dutch Residential Real Estate Portfolio (Business Wire)
Sep-11-24 07:55AM	Douglas Dynamics Completes $64.2 Million Sale-Leaseback Transaction with TPG Angelo Gordon (GlobeNewswire)
Sep-06-24 03:08PM	Bondermans Wildcat Spawns New Hedge Fund, Invests $200 Million (Bloomberg)
Sep-03-24 04:20PM	Sixth Street Buys TPG Partners Stake at $10 Billion Value (Bloomberg)
04:05PM	TPG to Present at the Barclays Global Financial Services Conference (Business Wire)
05:46AM	Loading…
Aug-23-24 05:46AM	Oaktree Plans to Seek Partner for 3,800 Home Project in Dublin (Bloomberg)
Aug-22-24 09:00AM	TPG-Backed PS to be Acquired by Groupe ADP (Business Wire)
Aug-15-24 01:00AM	EQT Seeks $12.5 Billion for Next Asia Fund, Defying Gloom (Bloomberg)
Aug-06-24 03:39PM	TPG Points to Deal Acceleration Heading Into the Second Half (The Wall Street Journal)
08:00AM	TPG Reports Second Quarter 2024 Results (Business Wire)
Jul-18-24 12:06AM	Director Deborah Messemer Sells 4,089 Shares of TPG Inc (TPG) (GuruFocus.com)
Jul-16-24 04:49AM	Strength Seen in TPG Inc. (TPG): Can Its 5.1% Jump Turn into More Strength? (Zacks)
Jul-10-24 08:00AM	TPG to Announce Second Quarter 2024 Financial Results and Host Investor Call (Business Wire)
Jul-04-24 12:00PM	Upcoming Stock Spinoffs: Should You Pounce or Pass? (InvestorPlace)
Jun-28-24 08:00AM	TPG Establishes New Talent Management and Representation Company to Invest in and Build a Scaled Talent-Centric Business (Business Wire)
07:55AM	Loading…
07:55AM	BOAT ROCKER SELLS MAJORITY STAKE IN UNTITLED ENTERTAINMENT TO LEADING GLOBAL ALTERNATIVE ASSET MANAGER TPG (PR Newswire)
Jun-17-24 09:30AM	K2 Medical Research and TPG Establish Partnership to Build a Leading Integrated Site Platform (Business Wire)
Jun-08-24 05:30PM	15 Most Advanced Countries in 5G Technology (Insider Monkey)
May-29-24 08:00AM	TPG to Present at the Morgan Stanley U.S. Financials, Payments & CRE Conference (Business Wire)
May-22-24 08:07AM	Full Truck Alliance Co. Ltd. (NYSE:YMM) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 12:54PM	TPG Stock Earnings: TPG Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:25AM	TPG Inc. (TPG) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:00AM	TPG Reports First Quarter 2024 Results (Business Wire)
May-02-24 01:00PM	Cencora (NYSE:COR) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 10:01AM	TPG Inc. (TPG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-24-24 12:10PM	Will TPG Inc. (TPG) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-17-24 09:00AM	Sayari Closes $235 Million Strategic Investment from TPG, Inclusive of Additional Capital for Organic Growth and M&A (Business Wire)
Apr-15-24 09:02AM	How CVC Would Stack Up Against Other Publicly Traded Buyout Firms (The Wall Street Journal)
Apr-04-24 08:00AM	TPG to Announce First Quarter 2024 Financial Results and Host Investor Call (Business Wire)
Apr-03-24 08:00AM	TPG Agrees to Acquire Classic Collision (Business Wire)
01:13AM	Loading…
Mar-29-24 01:13AM	TPG Rose 45% as Q3 Earnings Exceeded Expectations (Insider Monkey)
Mar-24-24 11:00AM	Sumitomo Life Insurance Forecasts Higher Overseas Earnings (Bloomberg)
Mar-07-24 10:05AM	Climate-Data Startup With All-Star Investors and Roots in Africa Nearly Collapses (The Wall Street Journal)
Mar-04-24 09:40AM	Salesforce, Inc. (NYSE:CRM) Q4 2024 Earnings Call Transcript (Updated) (Insider Monkey)
Mar-01-24 11:36PM	TPG Inc Director Deborah Messemer Sells 6,390 Shares (GuruFocus.com)
Feb-29-24 05:25PM	TPG Announces Pricing of Senior Notes (Business Wire)
09:19AM	Green Dot Corporation (NYSE:GDOT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 09:10PM	TPG Announces Pricing of Fixed-Rate Junior Subordinated Notes (Business Wire)
Feb-27-24 08:50AM	TPG Announces Public Offering of Senior Notes and Fixed-Rate Junior Subordinated Notes (Business Wire)
Feb-26-24 09:11AM	TPG Announces Pricing of Secondary Public Offering (Business Wire)
06:25AM	TPG Announces Launch of Secondary Public Offering (Business Wire)
Feb-21-24 09:06AM	JetBlue raised fees for checked bags earlier this month (Quartz)
Feb-20-24 01:46PM	DigitalBridge Stock Falls After the Companys Earnings Report. What Is Moving Shares. (Barrons.com)
Feb-19-24 01:16PM	TPG in Talks on 4.5 Billion Deal for Permiras Alter Domus (Bloomberg)
Feb-14-24 08:00AM	TPG to Present at the BofA Securities 2024 Financial Services Conference (Business Wire)
Feb-13-24 09:25AM	TPG Inc. (TPG) Q4 Earnings and Revenues Beat Estimates (Zacks)
08:00AM	TPG Reports Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-06-24 10:00AM	Analysts Estimate TPG Inc. (TPG) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-05-24 10:27AM	Scott Lebovitz Joins TPG as Partner to Lead TPG Rise Climate Infrastructure Investing (Business Wire)
Jan-24-24 06:32PM	3 Financial Services Stocks to Bank on for a Prosperous 2024 (InvestorPlace)
Jan-23-24 04:58PM	Top 7 Millionaire-Maker Stocks to Buy for a 10-Fold Return (InvestorPlace)
08:47AM	TPG Announces Investment in Compass Surgical Partners to Fuel Growth in Ambulatory Surgery Center Joint Ventures (Business Wire)
08:00AM	TPG to Invest in G&A Partners (Business Wire)
Jan-18-24 05:46PM	Australias Top Pension Says Buy Private Equity in Tough Times (Bloomberg)
Jan-16-24 03:48PM	TPG Acquires Supply-Chain Risk Company Sayari Labs (The Wall Street Journal)
09:00AM	TPG Announces $228 Million Strategic Growth Investment in Sayari, a Leading Counterparty & Supply Chain Risk Platform (Business Wire)
Jan-11-24 08:00AM	The Visualize Group and TPG Form Strategic Partnership (Business Wire)
Jan-10-24 08:00AM	TPG to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Investor Call (Business Wire)
Dec-27-23 07:47AM	Should You Add TPG (TPG)? (Insider Monkey)
Dec-18-23 01:24PM	TPG ACQUIRES MAJORITY OF OXFORD'S GREATER TORONTO AREA INDUSTRIAL PORTFOLIO FOR C$1 BILLION IN NEW JOINT VENTURE (PR Newswire)
Dec-15-23 07:55AM	TPG Expands Board of Directors (Business Wire)
Dec-01-23 06:06AM	ALTÉRRA Commits US$1.5 Billion to TPG Rise Climates US$10 Billion Next Generation Private Equity Funds Including New Global South Initiative and TPG Rise Climate II (Business Wire)
Nov-21-23 08:00AM	TPG to Present at the Goldman Sachs 2023 U.S. Financial Services Conference (Business Wire)
Nov-07-23 03:20PM	When Private-Equity Giants Sell, Investors Buy Their Stocks (The Wall Street Journal)
08:00AM	TPG Reports Third Quarter 2023 Financial Results (Business Wire)
05:30AM	Your Next Airbnb Host Could Be a Private-Equity Firm (The Wall Street Journal)
Nov-06-23 08:33AM	TPG RE Finance Trust, Inc. (NYSE:TRTX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 07:00AM	TPG Completes Acquisition of Angelo Gordon (Business Wire)
Oct-11-23 08:00AM	TPG to Announce Third Quarter 2023 Financial Results and Host Investor Call (Business Wire)
Oct-02-23 08:00AM	TPG Completes Acquisition of Forcepoint Global Governments and Critical Infrastructure Cybersecurity Business from Francisco Partners (Business Wire)
Sep-25-23 01:33PM	Meta: SEC expands probe into Wall Street's personal mesages (Yahoo Finance Video)
Sep-20-23 12:13AM	TPG Appoints Ganen Sarvananthan as Managing Partner to Lead Asia and the Middle East (Business Wire)
Sep-19-23 09:00AM	TPG explores sale of restaurant chain Mendocino Farms -sources (Reuters)
Sep-13-23 08:30AM	TPG to Invest $336 Million in Denodo to Accelerate Growth of the Data Management Leader (Business Wire)
Sep-05-23 12:31PM	TPG Appoints Anilu Vazquez-Ubarri as Chief Operating Officer (Business Wire)
08:00AM	Morrow Sodali Names Barri Rafferty as CEO of the Americas (Business Wire)
Aug-28-23 12:00PM	Flavio Porciani Joins TPG as Partner to Lead European Software and Enterprise Technology for TPG Capital (Business Wire)
Aug-12-23 08:04AM	Don't Buy TPG Inc. (NASDAQ:TPG) For Its Next Dividend Without Doing These Checks (Simply Wall St.)
Aug-09-23 08:40AM	TPG's (NASDAQ:TPG one-year decrease in earnings delivers investors with a 11% loss (Simply Wall St.)
Aug-08-23 08:00AM	TPG Reports Second Quarter 2023 Financial Results (Business Wire) -7.28%
Jul-31-23 01:39PM	New Relic Agrees to $6.5 Billion Take-Private Deal With Francisco Partners, TPG (The Wall Street Journal)
Jul-27-23 04:05PM	Digital Realty and TPG Announce Joint Venture of Hyperscale Data Centers in Northern Virginia (PR Newswire)
Jul-19-23 11:31AM	TPG to Acquire Leading Specialty Healthcare IT Platform Nextech (Business Wire)
Jul-11-23 08:30AM	TPG to Announce Second Quarter 2023 Financial Results and Host Investor Call (Business Wire)
Jul-10-23 07:00AM	TPG To Acquire Forcepoint Global Governments and Critical Infrastructure Business from Francisco Partners (Business Wire)
Jun-09-23 08:18AM	TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology (Business Wire)
Jun-05-23 08:30AM	TPG to Present at the Morgan Stanley U.S. Financials, Payments & CRE Conference (Business Wire)
May-18-23 07:12AM	TPG's (NASDAQ:TPG) Shareholders Will Receive A Smaller Dividend Than Last Year (Simply Wall St.)
May-17-23 04:31PM	Software Company New Relic in Talks to Be Sold (The Wall Street Journal)
May-15-23 03:54PM	TPG Looks to Expand Credit Reach With Angelo Gordon Acquisition (The Wall Street Journal)
06:30AM	TPG to Acquire Angelo Gordon (Business Wire)
06:30AM	TPG Reports First Quarter 2023 Financial Results (Business Wire)
May-03-23 09:00AM	Ayanna Clunis Joins TPG as a Partner and Head of Operations (Business Wire)
May-02-23 04:30PM	TPG to Announce First Quarter 2023 Financial Results and Host Investor Call (Business Wire)
Apr-20-23 08:30AM	TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic (Business Wire)
Apr-04-23 12:00PM	Thomson Reuters and TPG to Establish Elite as an Independent Legal Tech Company (Business Wire)
Mar-31-23 06:30AM	Technology Slump Refocuses Startups on Capital Discipline (The Wall Street Journal)
Feb-16-23 06:31AM	TPG (NASDAQ:TPG) grows 8.1% this week, taking one-year gains to 23% (Simply Wall St.)
Feb-15-23 08:00AM	TPG Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire) +6.24%
Jan-18-23 08:30AM	TPG to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Investor Call (Business Wire)

TPG, Inc. operates as a global, diversified alternative asset management firm. It invests across five multi-product platforms: Capital, Growth, Impact, Real Estate, and Market Solutions. The firm aims to build dynamic products and options for its clients while also instituting discipline and operational excellence across the investment strategy and performance of its portfolio. The company was founded by Jim Coulter and David Bonderman in 1992 and is headquartered in Fort Worth, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MESSEMER DEBORAH M.	Director	Jul 17 '24	Sale	46.55	4,089	190,332	17,536	Jul 17 05:37 PM
MESSEMER DEBORAH M.	Director	Feb 28 '24	Sale	43.97	6,390	280,980	18,033	Mar 01 05:14 PM
Vazquez-Ubarri Anilu	Chief Operating Officer	Feb 27 '24	Option Exercise	0.00	101,937	0	435,648	Feb 29 07:23 PM
Vazquez-Ubarri Anilu	Chief Operating Officer	Feb 29 '24	Sale	41.64	101,937	4,244,657	333,711	Feb 29 07:23 PM
WINKELRIED JON	Chief Executive Officer	Feb 27 '24	Option Exercise	0.00	1,000,000	0	4,326,460	Feb 29 07:01 PM
WINKELRIED JON	Chief Executive Officer	Feb 29 '24	Sale	41.64	1,000,000	41,640,000	3,326,460	Feb 29 07:01 PM
WINKELRIED JON	Chief Executive Officer	Feb 29 '24	Sale	41.64	50,848	2,117,311	0	Feb 29 07:01 PM
Weingart Jack	Chief Financial Officer	Feb 27 '24	Option Exercise	0.00	308,468	0	1,084,450	Feb 29 06:57 PM
Weingart Jack	Chief Financial Officer	Feb 29 '24	Sale	41.64	308,468	12,844,608	775,982	Feb 29 06:57 PM
Trujillo David	Director	Feb 27 '24	Option Exercise	0.00	397,510	0	580,029	Feb 29 06:45 PM
Trujillo David	Director	Feb 29 '24	Sale	41.64	397,510	16,552,316	182,519	Feb 29 06:45 PM
Sisitsky Todd Benjamin	President	Feb 27 '24	Option Exercise	0.00	660,151	0	1,172,917	Feb 29 06:43 PM
Sisitsky Todd Benjamin	President	Feb 29 '24	Sale	41.64	660,151	27,488,688	512,766	Feb 29 06:43 PM
Sisitsky Todd Benjamin	President	Feb 29 '24	Sale	41.64	52,807	2,198,883	396,982	Feb 29 06:43 PM
Sarvananthan Ganendran	Director	Feb 27 '24	Option Exercise	0.00	162,707	0	215,093	Feb 29 06:41 PM
Sarvananthan Ganendran	Director	Feb 29 '24	Sale	41.64	172,705	7,191,436	42,388	Feb 29 06:41 PM
Rhodes Jeffrey K.	Director	Feb 27 '24	Option Exercise	0.00	408,675	0	585,167	Feb 29 06:38 PM
Rhodes Jeffrey K.	Director	Feb 29 '24	Sale	41.64	408,675	17,017,227	176,492	Feb 29 06:38 PM
Raj Nehal	Director	Feb 27 '24	Option Exercise	0.00	250,858	0	800,570	Feb 29 06:36 PM
Raj Nehal	Director	Feb 29 '24	Sale	41.64	250,858	10,445,727	549,712	Feb 29 06:36 PM
Harris Joann	Chief Compliance Officer	Feb 27 '24	Option Exercise	0.00	23,745	0	23,745	Feb 29 06:33 PM
Harris Joann	Chief Compliance Officer	Feb 29 '24	Sale	41.64	23,745	988,742	0	Feb 29 06:33 PM
Harris Joann	Chief Compliance Officer	Feb 29 '24	Sale	41.64	1,739	72,412	22,860	Feb 29 06:33 PM
Davis Kelvin L.	Director	Feb 27 '24	Option Exercise	0.00	822,017	0	1,666,601	Feb 29 06:29 PM
Davis Kelvin L.	Director	Feb 29 '24	Sale	41.64	822,017	34,228,788	844,584	Feb 29 06:29 PM
Davidson Martin	Chief Accounting Officer	Feb 27 '24	Option Exercise	0.00	39,317	0	70,308	Feb 29 06:26 PM
Davidson Martin	Chief Accounting Officer	Feb 29 '24	Sale	41.64	39,317	1,637,160	30,991	Feb 29 06:26 PM
COULTER JAMES G	Executive Chairman	Feb 27 '24	Option Exercise	0.00	1,250,000	0	1,266,949	Feb 29 06:24 PM
COULTER JAMES G	Executive Chairman	Feb 29 '24	Sale	41.64	1,334,746	55,578,823	0	Feb 29 06:24 PM
COULTER JAMES G	Executive Chairman	Feb 29 '24	Sale	41.64	16,949	705,756	386,936	Feb 29 06:24 PM
COSLET JONATHAN J	Director	Feb 27 '24	Option Exercise	0.00	1,000,000	0	1,000,000	Feb 29 06:22 PM
COSLET JONATHAN J	Director	Feb 29 '24	Sale	41.64	1,000,000	41,640,000	0	Feb 29 06:22 PM
Chorengel Maya	Director	Feb 27 '24	Option Exercise	0.00	69,298	0	131,919	Feb 29 06:20 PM
Chorengel Maya	Director	Feb 29 '24	Sale	41.64	74,773	3,113,548	57,146	Feb 29 06:20 PM
BONDERMAN DAVID	Director	Feb 27 '24	Option Exercise	0.00	1,500,000	0	1,516,949	Feb 29 06:18 PM
BONDERMAN DAVID	Director	Feb 29 '24	Sale	41.64	1,584,746	65,988,823	0	Feb 29 06:18 PM
BONDERMAN DAVID	Director	Feb 29 '24	Sale	41.64	16,949	705,756	37,967	Feb 29 06:18 PM
Berenson Bradford	General Counsel	Feb 27 '24	Option Exercise	0.00	90,895	0	287,147	Feb 29 06:15 PM
Berenson Bradford	General Counsel	Feb 29 '24	Sale	41.64	90,895	3,784,868	196,252	Feb 29 06:15 PM

Open in Screener

ALLO

Allogene Therapeutics Inc

Sep 20 • 04:00PM ET

2.80

Dollar change -0.11
Percentage change -3.78	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

ALLO Allogene Therapeutics Inc daily Stock Chart

Held by: XBI VTI IWM VXF IWN IBB SCHA KOMP DFAC VHT

Index	RUT	P/E	-	EPS (ttm)	-1.61	Insider Own	34.69%	Shs Outstand	167.13M	Perf Week	-5.41%
Market Cap	585.51M	Forward P/E	-	EPS next Y	-1.49	Insider Trans	2.39%	Shs Float	136.57M	Perf Month	2.19%
Income	-278.45M	PEG	-	EPS next Q	-0.33	Inst Own	66.87%	Short Float	28.51%	Perf Quarter	9.80%
Sales	0.09M	P/S	6505.64	EPS this Y	32.39%	Inst Trans	4.06%	Short Ratio	15.85	Perf Half Y	-36.07%
Book/sh	2.46	P/B	1.14	EPS next Y	-5.29%	ROA	-39.28%	Short Interest	38.94M	Perf Year	-25.73%
Cash/sh	2.13	P/C	1.32	EPS next 5Y	1.00%	ROE	-48.94%	52W Range	2.01 - 5.78	Perf YTD	-12.77%
Dividend Est.	-	P/FCF	-	EPS past 5Y	22.18%	ROI	-46.25%	52W High	-51.52%	Beta	0.83
Dividend TTM	-	Quick Ratio	12.25	Sales past 5Y	-27.79%	Gross Margin	-16467.44%	52W Low	39.30%	ATR (14)	0.23
Dividend Ex-Date	-	Current Ratio	12.25	EPS Y/Y TTM	34.36%	Oper. Margin	-314866.28%	RSI (14)	53.03	Volatility	8.09% 8.38%
Employees	233	Debt/Eq	0.18	Sales Y/Y TTM	-24.70%	Profit Margin	-323780.23%	Recom	1.61	Target Price	9.34
Option/Short	Yes / Yes	LT Debt/Eq	0.17	EPS Q/Q	34.27%	Payout	-	Rel Volume	2.05	Prev Close	2.91
Sales Surprise	-99.92%	EPS Surprise	0.00%	Sales Q/Q	-100.00%	Earnings	Aug 07 AMC	Avg Volume	2.46M	Price	2.80
SMA20	4.05%	SMA50	3.09%	SMA200	-13.10%	Trades		Volume	5,038,024	Change	-3.78%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-08-24	Resumed	Oppenheimer	Outperform	$13 → $11
May-31-24	Initiated	Piper Sandler	Overweight	$11
Jan-05-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jan-05-24	Downgrade	Guggenheim	Buy → Neutral
Dec-08-23	Initiated	Citigroup	Buy	$7
Dec-08-23	Initiated	Citigroup	Buy
Jun-26-23	Resumed	Oppenheimer	Outperform	$28
Mar-21-23	Initiated	Bernstein	Mkt Perform	$6
Jan-24-23	Upgrade	JP Morgan	Neutral → Overweight	$20 → $11
Jan-06-23	Upgrade	Robert W. Baird	Neutral → Outperform	$12
Dec-12-22	Downgrade	BofA Securities	Buy → Underperform	$24 → $9
Aug-10-22	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-15-22	Upgrade	Goldman	Neutral → Buy	$9 → $32
Jun-03-22	Initiated	Robert W. Baird	Neutral	$11
Feb-28-22	Reiterated	B. Riley Securities	Buy	$30 → $21
Oct-20-21	Initiated	Cowen	Outperform
Oct-08-21	Downgrade	Stifel	Buy → Hold	$44 → $18
Oct-08-21	Downgrade	Goldman	Buy → Neutral	$71 → $20
Sep-23-21	Upgrade	Raymond James	Mkt Perform → Outperform
Jun-21-21	Resumed	Jefferies	Buy	$53

Show Previous Ratings

Sep-14-24 05:39PM	Allogene Therapeutics, Inc. (ALLO): Short Seller Sentiment is Bearish on This Cancer Stock (Insider Monkey)
Sep-06-24 11:31AM	Allogene Therapeutics (ALLO) Up 6.4% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-08-24 09:50AM	Allogene (ALLO) Posts Narrower Than Expected Loss in Q2 (Zacks)
08:30AM	Allogene Therapeutics Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
06:00AM	7 Biotech Stocks to Buy for Their Game-Changing Potential (InvestorPlace)
04:10PM	Loading…
Aug-07-24 04:10PM	Allogene Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
04:02PM	Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update (GlobeNewswire)
Jul-31-24 08:30AM	Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update (GlobeNewswire)
Jul-01-24 08:30AM	Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL) (GlobeNewswire)
Jun-27-24 10:13AM	Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of This Small-Cap Stock? (Insider Monkey)
Jun-26-24 04:36PM	Top 10 Small-Cap Stocks with Highest Upside Potential (Insider Monkey)
Jun-20-24 08:30AM	Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse (GlobeNewswire) +9.42%
Jun-12-24 11:30AM	Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound? (Zacks)
May-29-24 08:55AM	Insiders Pour Millions Into These 2 Strong Buy Stocks (TipRanks)
May-28-24 04:05PM	If You Can Only Buy One Penny Stock in May, It Better Be One of These 3 Names (InvestorPlace)
08:30AM	Loading…
May-23-24 08:30AM	Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit (GlobeNewswire)
May-21-24 01:56PM	Hedge Fund and Insider Trading News: Ken Griffin, Sanjay Shah, David Tepper, Stanley Druckenmiller, Michael Burry, Cevian Capital, Elliott Management, Millennium Management, Eisler Capital, Allogene Therapeutics Inc (ALLO), Carvana Co. (CVNA) and More (Insider Monkey)
08:16AM	Oppenheimer Trims Allogene Therapeutics Price Target to $13 From $14, Maintains Outperform Rating (MT Newswires)
May-16-24 08:13AM	HC Wainwright Adjusts Price Target on Allogene Therapeutics to $9 From $10, Keeps Buy Rating (MT Newswires)
May-14-24 12:56PM	Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag (Zacks)
09:14AM	Stifel Adjusts Price Target on Allogene Therapeutics to $4.60 From $4.40, Keeps Hold Rating (MT Newswires)
08:21AM	B. Riley Adjusts Price Target on Allogene Therapeutics to $7 From $10, Keeps Buy Rating (MT Newswires)
03:06AM	Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-13-24 08:55PM	ALLO Stock Earnings: Allogene Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +5.07%
05:36PM	Allogene Therapeutics Prices $110 Million Offering (MT Newswires)
05:10PM	Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:47PM	Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock (GlobeNewswire)
04:17PM	Allogene Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:14PM	Allogene Therapeutics Q1 Loss Narrows, Revenue Declines (MT Newswires)
04:01PM	Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update (GlobeNewswire)
08:30AM	Loading…
May-06-24 08:30AM	Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update (GlobeNewswire)
Apr-26-24 10:32AM	Allogene Therapeutics Gets $15 Million Grant from California Institute for Regenerative Medicine for Cancer Drug Development (MT Newswires)
08:30AM	Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma (GlobeNewswire)
Apr-24-24 10:01AM	Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) -9.79%
Apr-11-24 02:45PM	3 Meme Stocks to Sell and Replace With Meme Coins (InvestorPlace)
Apr-09-24 08:30AM	Allogene Therapeutics Announces Q2 Investor Conference Participation (GlobeNewswire)
Apr-08-24 08:46AM	How Allogene (ALLO) Stock Stands Out in a Strong Industry (Zacks)
Mar-16-24 04:35PM	Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-15-24 09:32AM	Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss (Zacks)
07:04AM	Q4 2023 Allogene Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	ALLO Stock Earnings: Allogene Therapeutics Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -7.89%
05:34PM	Allogene Therapeutics Inc (ALLO) Reports Q4 and Full Year 2023 Financials, Forecasts Cash ... (GuruFocus.com)
05:15PM	Allogene Therapeutics (ALLO) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:15PM	Allogene Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update (GlobeNewswire)
Mar-13-24 12:15PM	Allogene (ALLO) Inks Deal With Arbor Bio for CRISPR Technology (Zacks)
Mar-12-24 08:50AM	Allogene taps Arbor in pursuit of off-the-shelf CAR-T therapies for autoimmune disease (BioPharma Dive)
08:30AM	Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease (GlobeNewswire)
Mar-05-24 09:55AM	Allogene Therapeutics (ALLO)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
08:30AM	Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update (GlobeNewswire)
Feb-28-24 08:30AM	Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference (GlobeNewswire)
Feb-16-24 08:30AM	Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia (GlobeNewswire)
Jan-16-24 04:05PM	Allogene Therapeutics Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
Jan-12-24 08:34AM	How Allogene (ALLO) Stock Stands Out in a Strong Industry (Zacks)
Jan-05-24 12:52PM	Allogene (ALLO) Down 20% on Strategic Changes in Pipeline (Zacks) -14.01%
08:25AM	UPDATE 2-Allogene to cut 22% of its workforce (Reuters)
08:13AM	Allogene to cut 22% of its workforce (Reuters)
Jan-04-24 04:15PM	Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma (GlobeNewswire)
04:05PM	Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma (GlobeNewswire)
11:05AM	Allogene to shift strategy in bid to reposition CAR-T (BioPharma Dive)
Jan-03-24 04:05PM	Allogene Therapeutics to Host Conference Call Previewing its 2024 Platform Vision and Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -8.01%
Dec-09-23 12:00PM	Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the American Society of Hematology (GlobeNewswire)
Dec-01-23 08:30AM	Allogene Therapeutics Announces Participation in December Investor Conference (GlobeNewswire) +7.23%
Nov-24-23 06:40AM	7 Penny Stocks With Low Floats and High Short Interest (InvestorPlace)
Nov-10-23 12:00PM	Allogene Therapeutics (ALLO) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Nov-03-23 12:15PM	Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2023 Earnings Call Transcript (Insider Monkey) +17.85%
12:00PM	Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak and Dagger Technologies at the Society for Immunotherapy of Cancer Annual Meeting (GlobeNewswire)
12:00PM	Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting (GlobeNewswire)
10:15AM	Allogene's (ALLO) Q3 Loss Narrower Than Expected, Sales Miss (Zacks)
Nov-02-23 07:33PM	Allogene Therapeutics Inc (ALLO) Reports Q3 2023 Financial Results (GuruFocus.com)
04:12PM	Allogene Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update (GlobeNewswire)
09:00AM	Allogene Therapeutics Announces Poster Presentations at the 65th Annual Meeting of the American Society of Hematology (GlobeNewswire)
Oct-30-23 08:30AM	Allogene Therapeutics Announces Participation in November Investor Conferences (GlobeNewswire) +9.09%
Oct-26-23 08:30AM	Allogene Therapeutics to Report Third Quarter 2023 Financial Results on November 2, 2023 (GlobeNewswire)
Oct-16-23 09:26AM	The Zacks Analyst Blog Highlights Pfizer, Allogene Therapeutics and Corcept Therapeutics (Zacks)
08:30AM	Allogene Therapeutics Appoints Geoffrey Parker as Chief Financial Officer (GlobeNewswire)
Sep-27-23 09:09AM	Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Sep-25-23 08:45AM	JP Morgan maintains Overweight recommendation on Allogene Therapeutics amid bullish market sentiment (Investing.com)
Sep-05-23 08:30AM	Allogene Therapeutics Announces Participation in September Investor Conference (GlobeNewswire)
Aug-29-23 07:30AM	16 Most Shorted Stocks Right Now (Insider Monkey)
Aug-23-23 12:26PM	11 Best High Short Interest Stocks To Buy Now (Insider Monkey)
Aug-17-23 08:44AM	11 Best Biotech Penny Stocks to Buy Now (Insider Monkey)
Aug-14-23 08:30AM	Allogene Therapeutics Appoints Earl Douglas as General Counsel (GlobeNewswire)
Aug-03-23 11:20AM	Allogene's (ALLO) Q2 Loss Narrower Than Expected, Sales Miss (Zacks) +9.59%
Aug-02-23 05:25PM	Allogene Therapeutics (ALLO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:13PM	Allogene Therapeutics: Q2 Earnings Snapshot (AP Finance)
04:02PM	Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update (GlobeNewswire)
10:41AM	Too Cheap to Ignore: J.P. Morgan Says These 2 Stocks Under $10 Could Double Your Money (TipRanks)
Jul-26-23 08:30AM	Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023 (GlobeNewswire)
Jun-15-23 09:30AM	Allogene Therapeutics Provides Additional ALLO-501/501A Phase 1 Data in an Oral Presentation at the International Conference on Malignant Lymphoma (ICML) Lugano (GlobeNewswire)
Jun-14-23 08:00AM	Allogene Therapeutics Announces Departure of Chief Financial Officer (GlobeNewswire) -12.54%
Jun-09-23 06:25PM	Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) Lugano (GlobeNewswire)
08:02AM	12 Best Short Squeeze Stocks to Buy Now (Insider Monkey)
Jun-03-23 09:00AM	Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Jun-02-23 11:31AM	Allogene Therapeutics (ALLO) Down 17.5% Since Last Earnings Report: Can It Rebound? (Zacks) +5.45%
May-31-23 12:02PM	Sanofi (SNY) NextGen Multiple Sclerosis Drug Meets Phase II Goal (Zacks)
10:46AM	J&J (JNJ) Submits NDA for Single Tablet Combo to Treat PAH (Zacks)
May-29-23 07:48AM	AstraZeneca (AZN) Drug Combo Meets Endometrial Cancer Study Goal (Zacks)
May-26-23 10:51AM	Apellis' (APLS) Study on Pegcetacoplan to Treat ALS Fails (Zacks)

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Douglas Earl Martin	Officer	Aug 21 '24	Proposed Sale	2.79	28,310	78,844		Aug 21 04:18 PM
MESSEMER DEBORAH M.	Director	Jun 18 '24	Sale	2.28	18,641	42,488	166,765	Jun 20 04:31 PM
Humer Franz B	Director	May 30 '24	Sale	2.34	11,200	26,181	255,253	Jun 03 04:09 PM
Belldegrun Arie	Director	May 16 '24	Buy	2.90	1,724,137	4,999,997	1,724,137	May 20 09:33 PM
Parker Geoffrey M.	CHIEF FINANCIAL OFFICER	Jan 30 '24	Buy	3.60	190	683	819,590	Mar 06 09:52 PM
MESSEMER DEBORAH M.	Director	Dec 18 '23	Sale	2.70	18,640	50,317	62,456	Dec 20 04:26 PM

Open in Screener

PYPL

PayPal Holdings Inc

Sep 20 • 04:00PM ET

76.76

Dollar change -0.81
Percentage change -1.04	%

Financial • Credit Services • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

PYPL PayPal Holdings Inc daily Stock Chart

Held by: VTI VOO QQQ SPY IVV VTV XLF FDN IWD QQQM

Index	NDX, S&P 500	P/E	18.59	EPS (ttm)	4.13	Insider Own	0.40%	Shs Outstand	1.07B	Perf Week	9.50%
Market Cap	78.47B	Forward P/E	15.93	EPS next Y	4.82	Insider Trans	-0.11%	Shs Float	1.02B	Perf Month	7.42%
Income	4.44B	PEG	0.96	EPS next Q	1.06	Inst Own	71.45%	Short Float	2.23%	Perf Quarter	26.65%
Sales	31.04B	P/S	2.53	EPS this Y	-13.30%	Inst Trans	1.53%	Short Ratio	1.85	Perf Half Y	16.06%
Book/sh	19.98	P/B	3.84	EPS next Y	8.97%	ROA	5.60%	Short Interest	22.68M	Perf Year	26.13%
Cash/sh	13.32	P/C	5.76	EPS next 5Y	19.45%	ROE	22.03%	52W Range	50.25 - 78.25	Perf YTD	25.00%
Dividend Est.	-	P/FCF	11.71	EPS past 5Y	17.54%	ROI	14.32%	52W High	-1.90%	Beta	1.44
Dividend TTM	-	Quick Ratio	1.24	Sales past 5Y	14.06%	Gross Margin	39.61%	52W Low	52.76%	ATR (14)	2.16
Dividend Ex-Date	-	Current Ratio	1.24	EPS Y/Y TTM	15.58%	Oper. Margin	17.58%	RSI (14)	70.04	Volatility	2.81% 2.80%
Employees	27200	Debt/Eq	0.63	Sales Y/Y TTM	10.24%	Profit Margin	14.30%	Recom	2.14	Target Price	80.35
Option/Short	Yes / Yes	LT Debt/Eq	0.50	EPS Q/Q	16.64%	Payout	0.00%	Rel Volume	2.23	Prev Close	77.57
Sales Surprise	0.79%	EPS Surprise	20.34%	Sales Q/Q	8.40%	Earnings	Jul 30 BMO	Avg Volume	12.24M	Price	76.76
SMA20	7.36%	SMA50	15.55%	SMA200	21.43%	Trades		Volume	27,251,620	Change	-1.04%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-09-24	Upgrade	Daiwa Securities	Neutral → Outperform	$68 → $72
Jul-31-24	Upgrade	Bernstein	Mkt Perform → Outperform	$71 → $78
Jul-31-24	Upgrade	Argus	Hold → Buy
Jul-18-24	Downgrade	William Blair	Outperform → Mkt Perform
Jul-02-24	Upgrade	Susquehanna	Neutral → Positive	$71
Jun-24-24	Resumed	Goldman	Neutral	$69
May-31-24	Initiated	New Street	Buy	$80
May-30-24	Upgrade	Mizuho	Neutral → Buy	$68 → $90
Apr-29-24	Reiterated	Monness Crespi & Hardt	Buy	$80 → $88
Feb-13-24	Downgrade	Daiwa Securities	Outperform → Neutral	$64 → $62
Feb-09-24	Downgrade	DZ Bank	Buy → Hold	$60
Feb-09-24	Downgrade	Argus	Buy → Hold
Feb-08-24	Reiterated	Monness Crespi & Hardt	Buy	$95 → $80
Jan-29-24	Reiterated	Monness Crespi & Hardt	Buy	$100 → $95
Jan-16-24	Downgrade	Mizuho	Buy → Neutral	$72 → $65
Jan-09-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$118 → $66
Jan-05-24	Downgrade	BTIG Research	Buy → Neutral
Jan-04-24	Downgrade	Oppenheimer	Outperform → Perform
Dec-06-23	Downgrade	BofA Securities	Buy → Neutral	$77 → $66
Dec-05-23	Resumed	BMO Capital Markets	Market Perform	$65

Show Previous Ratings

Today 01:47PM	Call of the Day: PayPal (CNBC TV)
09:37AM	Jim Cramer Says PayPal (PYPL) is a Buy Because CEO Alex Chriss is Miracle Worker (Insider Monkey)
Sep-19-24 10:37AM	Apple, Alibaba, PayPal and Amazon: 3 Stories In Focus (Yahoo Finance Video) +6.09%
08:20AM	Amazon adds PayPal payment option to Buy with Prime (Retail Dive)
Sep-18-24 05:45PM	Paypal (PYPL) Ascends While Market Falls: Some Facts to Note (Zacks)
01:55PM	Loading…
01:55PM	PayPal, Amazon Team Up in First Step of Branded Checkout Collaboration (Barrons.com)
12:24PM	PayPal Stock Rises On Amazon Prime Checkout Partnership (Investor's Business Daily)
07:58AM	Fintech Giant Revolut Said to Be Planning Stablecoin (CoinDesk)
Sep-17-24 05:15AM	Shopify, Fiserv, and Adyen Just Partnered With This Beaten-Down Financial Stock. Is This Good for Investors? (Motley Fool)
Sep-16-24 08:52AM	Life in the Fast Lane for PayPal? New Partnerships Could Boost the Stock. (Barrons.com)
06:11AM	2 Stocks Down 78% and 88% That Wall Street Is Overlooking -- but I'm Not (Motley Fool)
Sep-15-24 10:55AM	Jim Cramer Now Bullish on PayPal Holdings Inc. (PYPL) Thanks to Leadership of Alex Chriss (Insider Monkey)
Sep-14-24 04:30PM	PayPal Holdings, Inc. (PYPL): Among the Best Fintech Stocks to Buy in 2024 (Insider Monkey)
02:55PM	PayPal Holdings, Inc. (PYPL): A Bull Case Theory (Insider Monkey)
05:45AM	PayPal Stock: Buy, Sell, or Hold? (Motley Fool)
12:55PM	Loading…
Sep-13-24 12:55PM	Tether Hires PayPal Government Affairs Ace as U.S. Scrutiny Unresolved (CoinDesk)
06:50AM	Forget PayPal: Billionaires Are Buying Up This Fintech Stock Instead (Motley Fool)
Sep-12-24 06:16PM	Affirm founder: We want to be the modern American Express (Yahoo Finance)
05:45PM	Paypal (PYPL) Exceeds Market Returns: Some Facts to Consider (Zacks)
09:40AM	Are Investors Undervaluing PayPal (PYPL) Right Now? (Zacks)
06:19AM	3 No-Brainer Fintech Stocks to Buy Right Now for Less Than $200 (Motley Fool)
05:36AM	Bold Commerce and PayPal bring Fastlane to Magento retailers (Retail Insight Network)
Sep-11-24 09:37PM	PayPal's Growth Challenges and Undervaluation: A Long-Term Opportunity for Investors (Insider Monkey)
09:08PM	Lightning Round: I'm a buyer of PayPal, says Jim Cramer (CNBC TV)
05:43PM	PayPal Holdings, Inc. (PYPL): Hedge Funds Are Bullish On This Cryptocurrency Stock (Insider Monkey)
12:35PM	Lightspark: disrupting payments with cryptocurrency (Electronic Payments)
10:00AM	Mastercard Outpaces Visa in Growth With Low Volatility Risk (GuruFocus.com)
Sep-10-24 12:00PM	PayPal, Venmo to Accept ENS's Human-Readable Blockchain Names (CoinDesk)
09:00AM	PayPal Holdings, Inc. (PYPL) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
05:11AM	PayPal takes Will Ferrell Everywhere for largest-ever US ad campaign (Marketing Dive)
05:59PM	Loading…
Sep-09-24 05:59PM	Shopify Adds PayPal as Payment Processor in the U.S. (The Information)
12:18PM	PayPal teams with Will Ferrell in major omnichannel promotion (Chain Store Age)
08:00AM	Will Ferrell Goes Shopping 'Everywhere' in PayPal's Biggest US Campaign Ever (PR Newswire)
07:00AM	PayPal Teams Up With Shopify in CEOs Latest Partnership Deal (Bloomberg)
Sep-07-24 03:06PM	Peter Thiel Supports Trump, Backed Ethereum's Buterin: 5 Facts You Might Not Know About PayPal, Palantir Co-Founder (Benzinga)
06:18AM	20 Best Cryptocurrency Stocks to Buy According to Hedge Funds (Insider Monkey)
05:40AM	Why PayPal's Latest Move Is a Big Win for Investors (Motley Fool)
Sep-06-24 04:00PM	How PayPal's rewards upgrade competes with banks (American Banker)
07:35AM	Why PayPal Stock Jumped 10% in August (Motley Fool)
05:55AM	PayPal Everywhere rewards programme launches (Electronic Payments)
05:45AM	2 Beaten-Down Stocks to Buy and Hold (Motley Fool)
Sep-05-24 08:05AM	PayPal pushes into in-person payments with cashback rewards, Apple integration (Reuters)
08:00AM	PayPal Sweetens Rewards Program As New CEO's Overhaul Gains Momentum (Investor's Business Daily)
08:00AM	Introducing PayPal Everywhere (PR Newswire)
07:21AM	Is this the Right Time to Purchase PayPal Holdings (PYPL)? (Insider Monkey)
04:06AM	1 Incredibly Cheap Fintech Stock to Buy Now (Motley Fool)
Sep-04-24 05:18AM	Don't Count Out Ethereum: Sony's Big Bet Signals a Bullish Future for the Cryptocurrency (Motley Fool)
04:00AM	Bull of the Day: PayPal (PYPL) (Zacks)
Aug-31-24 12:17PM	Is Solana the Next PayPal? (Motley Fool)
Aug-30-24 09:00AM	Investors Heavily Search PayPal Holdings, Inc. (PYPL): Here is What You Need to Know (Zacks)
05:45AM	2 Incredibly Cheap Growth Stocks to Buy Now (Motley Fool)
Aug-29-24 04:14PM	MoonPay: PayPal users now hold a 'passport' to the world of crypto (TheStreet)
02:07PM	The Committee's Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos (CNBC TV)
11:31AM	Paypal (PYPL) Up 7.1% Since Last Earnings Report: Can It Continue? (Zacks)
10:00AM	PayPal: A Rebound in Progress With Strong Upside Potential (GuruFocus.com)
07:00AM	PayPal Expands Strategic Partnership with Fiserv to Streamline Checkout Experiences in the U.S. (PR Newswire)
Aug-27-24 03:21PM	PayPal Holdings, Inc. (PYPL) A Bullish Perspective (Insider Monkey)
04:04AM	PYPL, SOFI, or SQ: Which Fintech Stock Scores Wall Streets Strong Buy Rating? (TipRanks)
02:53AM	PayPal's Stablecoin PYUSD Surpasses $1 Billion in Market Cap (CoinMarketCap)
Aug-26-24 08:42PM	Is It Too Late to Buy PayPal Stock? (Motley Fool)
03:56PM	PayPal Holdings, Inc. (PYPL): A Top Contender Among the Best Digital Currency and Payments Stocks (Insider Monkey)
02:40PM	PayPal's Stablecoin Hits $1B Market Cap as Incentives Boost Activity on Solana (CoinDesk)
10:00AM	2 No-Brainer Billionaire-Owned Stocks to Buy Right Now (Motley Fool)
Aug-25-24 02:16AM	7 Best Digital Currency and Payments Stocks To Buy Now (Insider Monkey)
Aug-23-24 03:45PM	3 Buys and a Bail: Peloton, Gap, PayPal, (CNBC TV)
Aug-22-24 03:39PM	This Fintech Trio Is Having a Better August Than the S&P 500 (Barrons.com)
09:00AM	PayPal partners with crypto platform Anchorage Digital to offer stablecoin rewardsdespite murky legal rules (Fortune)
Aug-21-24 08:31PM	PayPals stock soars to 52-week closing high as senior analyst praises new partnership with Adyen (Fortune)
Aug-20-24 05:25PM	S&P 500 Gains and Losses Today: Palo Alto Networks Surges After Earnings Beat (Investopedia)
01:30PM	Trade Tracker: Josh Brown buys PayPal (CNBC TV)
10:03AM	Forget Mastercard: Buy This Magnificent Payments Stock Instead (Motley Fool)
07:03AM	3 Cheap Tech Stocks to Buy Right Now (Motley Fool)
07:00AM	PayPal Expands Strategic Partnership with Adyen to offer Fastlane in the U.S. (PR Newswire)
Aug-19-24 09:00AM	Here is What to Know Beyond Why PayPal Holdings, Inc. (PYPL) is a Trending Stock (Zacks)
Aug-18-24 06:14PM	1 Incredibly Cheap Fintech Stock to Buy Now (Motley Fool)
08:30AM	Why new Starbucks CEO Brian Niccol is worth the $85 million and remote California office (Yahoo Finance)
Aug-17-24 08:00AM	Apple Opens Tap-to-Pay to Competitors, but Can They Take Advantage? (The Wall Street Journal)
06:50AM	3 Unstoppable Stocks to Buy for Less Than $100 (Motley Fool)
Aug-16-24 10:34AM	PayPal (PYPL) Gains 9.9% in a Month: Should You Buy the Stock? (Zacks)
Aug-15-24 05:23PM	PayPal Stock Rising Toward Buy Point Amid Strong Profit Growth (Investor's Business Daily)
02:02PM	Apple Opens Up Payment Options, Boosting PayPal Stock. This Analyst Sees Long-Term Positives. (Barrons.com)
Aug-14-24 10:28AM	Fintechs ramp up lobbying over earned wage access, crypto, AI (Banking Dive)
Aug-11-24 08:31AM	Prediction: These Could Be the Best-Performing Fintech Stocks Through 2030 (Motley Fool)
03:00AM	Huge Pension Started Buying CrowdStrike Stock Shortly Before Global Glitch (Barrons.com)
Aug-09-24 01:51PM	The 3 Best Fintech Stocks to Buy in August 2024 (InvestorPlace)
10:33AM	How PayPals Growth Story Edged a New Bull Off the Sidelines (Barrons.com)
09:53AM	Paramount, PayPal upgraded: Wall Street's top analyst calls (The Fly)
05:00AM	PayPal Stock: Buy, Sell, or Hold? (Motley Fool)
Aug-08-24 07:39AM	Did You Catch the Good News From PayPal? (Motley Fool)
04:40AM	Is PayPal Stock a Buy? (Motley Fool)
Aug-06-24 12:35PM	PayPal Stock Rises. Its on Fast Track to Better Margins With New Guest Checkout System. (Barrons.com)
09:00AM	PayPal Holdings, Inc. (PYPL) is Attracting Investor Attention: Here is What You Should Know (Zacks)
09:00AM	Fastlane by PayPal Enables a faster, simpler Guest Checkout Experience (PR Newswire)
Aug-05-24 09:40AM	PayPal, Kellanova upgraded: Wall Street's top analyst calls (The Fly)
07:52AM	3 No-Brainer Stocks to Buy Right Now for Less Than $100 (Motley Fool)
05:35AM	Is PayPal Stock Ridiculously Cheap? (Motley Fool)
05:13AM	3 Payments Stocks That Are Screaming Buys in August (Motley Fool)
Aug-04-24 12:25PM	Is PayPal a Value Stock or a Value Trap? (Motley Fool)
03:15AM	Street calls of the week: Upgrade for PayPal; downgrades for Etsy, Lululemon (Investing.com)
Aug-03-24 06:25AM	PayPal Shares Jump on Strong Guidance. Is It Too Late to Buy the Stock? (Motley Fool)

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Sep 01 '24	Option Exercise	0.00	3,296	0	28,386	Sep 03 07:34 PM
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Jun 01 '24	Option Exercise	0.00	3,296	0	26,726	Jun 03 09:01 PM
MESSEMER DEBORAH M.	Director	May 24 '24	Sale	61.65	4,422	272,616	13,976	May 24 05:09 PM
Keller Frank	SVP, GM, Lg Ent & Mer Plat.	Mar 01 '24	Sale	60.64	7,686	466,077	23,430	Mar 04 06:26 PM
Karczmer Aaron	EVP, Chief Enterprise Services	Mar 01 '24	Option Exercise	0.00	24,617	0	155,909	Mar 04 06:19 PM
Keller Frank	SVP, GM, Lg Ent & Mer Plat.	Mar 01 '24	Option Exercise	0.00	12,010	0	35,440	Mar 04 06:15 PM
Alford Peggy	EVP, Global Sales	Dec 01 '23	Option Exercise	0.00	3,069	0	43,670	Dec 04 08:00 PM
Auerbach Jonathan	Chief Strat., Gr & Data Ofr	Dec 01 '23	Option Exercise	0.00	3,069	0	82,120	Dec 04 07:59 PM
Karczmer Aaron	EVP, Chief Enterprise Services	Dec 01 '23	Option Exercise	0.00	3,069	0	125,929	Dec 04 07:59 PM
Alford Peggy	EVP, Global Sales	Nov 27 '23	Sale	56.76	15,000	851,428	40,601	Nov 28 05:45 PM
Auerbach Jonathan	Chief Strat., Gr & Data Ofr	Nov 21 '23	Sale	55.58	64,957	3,610,373	79,051	Nov 22 05:45 PM
Scheibe Gabrielle	Acting CFO & SVP, IR & Treas.	Oct 15 '23	Option Exercise	0.00	4,607	0	34,826	Oct 17 08:18 PM
Kim John C.	EVP, Chief Product Officer	Oct 15 '23	Option Exercise	0.00	22,114	0	22,715	Oct 17 08:14 PM

TPG

TPG Inc

ALLO

Allogene Therapeutics Inc

PYPL

PayPal Holdings Inc

Upgrade your FINVIZ experience